DRUG

Adalimumab

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Adalimumab

Inflammatory bowel disease 1

Mediator Outcome Score Tier Lit. status Trial
anti-drug antibodies loss of response 0.208 Mid reproduces known active

Clinical trials

200 registered trials for Adalimumab

Source: ClinicalTrials.gov